The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Mycoplasma Testing-Global Market Insights and Sales Trends 2025
Synopsis
The major factors driving this market are the increasing growth of government support for pharmaceutical and biotechnology industries, rising R&D activities in life sciences research, and rising cell culture contamination.
The global Mycoplasma Testing market size is expected to reach US$ 1054.7 million by 2029, growing at a CAGR of 11.3% from 2023 to 2029. The market is mainly driven by the significant applications of Mycoplasma Testing in various end use industries. The expanding demands from the Pharmaceuticals, Food And Beverage Testing, Biotechnology, Biomedical Drugs and Environmental Test, are propelling Mycoplasma Testing market. PCR, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the ELSA segment is estimated at % CAGR for the next seven-year period.
The Asia region is estimated to grow at the fastest rate which can be attributed to the increasing government investments in pharmaceutical R&D and the increasing trend of pharmaceutical outsourcing.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Mycoplasma Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Mycoplasma Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Mycoplasma Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Mycoplasma Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Mycoplasma Testing covered in this report include Charles River Laboratories International, Merck Kgaa, Lonza Group, Roche Diagnostics, SGS, Thermo Fisher Scientific, American Type Culture Collection, Biounique Testing Laboratories and Invivogen, etc.
The global Mycoplasma Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Charles River Laboratories International
Merck Kgaa
Lonza Group
Roche Diagnostics
SGS
Thermo Fisher Scientific
American Type Culture Collection
Biounique Testing Laboratories
Invivogen
Promocell
Biological Industries Israel Beit Haemek
Wuxi Apptec
Norgen Biotek
Global Mycoplasma Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Mycoplasma Testing market, Segment by Type:
PCR
ELSA
Enzymatic Methods
DNA Staining
Global Mycoplasma Testing market, by Application
Pharmaceuticals
Food And Beverage Testing
Biotechnology, Biomedical Drugs
Environmental Test
Academic Research Institute
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Mycoplasma Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The major factors driving this market are the increasing growth of government support for pharmaceutical and biotechnology industries, rising R&D activities in life sciences research, and rising cell culture contamination.
The global Mycoplasma Testing market size is expected to reach US$ 1054.7 million by 2029, growing at a CAGR of 11.3% from 2023 to 2029. The market is mainly driven by the significant applications of Mycoplasma Testing in various end use industries. The expanding demands from the Pharmaceuticals, Food And Beverage Testing, Biotechnology, Biomedical Drugs and Environmental Test, are propelling Mycoplasma Testing market. PCR, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the ELSA segment is estimated at % CAGR for the next seven-year period.
The Asia region is estimated to grow at the fastest rate which can be attributed to the increasing government investments in pharmaceutical R&D and the increasing trend of pharmaceutical outsourcing.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Mycoplasma Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Mycoplasma Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Mycoplasma Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Mycoplasma Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Mycoplasma Testing covered in this report include Charles River Laboratories International, Merck Kgaa, Lonza Group, Roche Diagnostics, SGS, Thermo Fisher Scientific, American Type Culture Collection, Biounique Testing Laboratories and Invivogen, etc.
The global Mycoplasma Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Charles River Laboratories International
Merck Kgaa
Lonza Group
Roche Diagnostics
SGS
Thermo Fisher Scientific
American Type Culture Collection
Biounique Testing Laboratories
Invivogen
Promocell
Biological Industries Israel Beit Haemek
Wuxi Apptec
Norgen Biotek
Global Mycoplasma Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Mycoplasma Testing market, Segment by Type:
PCR
ELSA
Enzymatic Methods
DNA Staining
Global Mycoplasma Testing market, by Application
Pharmaceuticals
Food And Beverage Testing
Biotechnology, Biomedical Drugs
Environmental Test
Academic Research Institute
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Mycoplasma Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Mycoplasma Testing
1.1 Mycoplasma Testing Market Overview
1.1.1 Mycoplasma Testing Product Scope
1.1.2 Mycoplasma Testing Market Status and Outlook
1.2 Global Mycoplasma Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Mycoplasma Testing Market Size by Region (2018-2029)
1.4 Global Mycoplasma Testing Historic Market Size by Region (2018-2023)
1.5 Global Mycoplasma Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Mycoplasma Testing Market Size (2018-2029)
1.6.1 North America Mycoplasma Testing Market Size (2018-2029)
1.6.2 Europe Mycoplasma Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Mycoplasma Testing Market Size (2018-2029)
1.6.4 Latin America Mycoplasma Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Mycoplasma Testing Market Size (2018-2029)
2 Mycoplasma Testing Market by Type
2.1 Introduction
2.1.1 PCR
2.1.2 ELSA
2.1.3 Enzymatic Methods
2.1.4 DNA Staining
2.2 Global Mycoplasma Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Mycoplasma Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Mycoplasma Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Mycoplasma Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Mycoplasma Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Mycoplasma Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Mycoplasma Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Mycoplasma Testing Revenue Breakdown by Type (2018-2029)
3 Mycoplasma Testing Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceuticals
3.1.2 Food And Beverage Testing
3.1.3 Biotechnology, Biomedical Drugs
3.1.4 Environmental Test
3.1.5 Academic Research Institute
3.1.6 Other
3.2 Global Mycoplasma Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Mycoplasma Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Mycoplasma Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Mycoplasma Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Mycoplasma Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Mycoplasma Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Mycoplasma Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Mycoplasma Testing Revenue Breakdown by Application (2018-2029)
4 Mycoplasma Testing Competition Analysis by Players
4.1 Global Mycoplasma Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Mycoplasma Testing as of 2022)
4.3 Date of Key Players Enter into Mycoplasma Testing Market
4.4 Global Top Players Mycoplasma Testing Headquarters and Area Served
4.5 Key Players Mycoplasma Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Mycoplasma Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Charles River Laboratories International
5.1.1 Charles River Laboratories International Profile
5.1.2 Charles River Laboratories International Main Business
5.1.3 Charles River Laboratories International Mycoplasma Testing Products, Services and Solutions
5.1.4 Charles River Laboratories International Mycoplasma Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Charles River Laboratories International Recent Developments
5.2 Merck Kgaa
5.2.1 Merck Kgaa Profile
5.2.2 Merck Kgaa Main Business
5.2.3 Merck Kgaa Mycoplasma Testing Products, Services and Solutions
5.2.4 Merck Kgaa Mycoplasma Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Merck Kgaa Recent Developments
5.3 Lonza Group
5.3.1 Lonza Group Profile
5.3.2 Lonza Group Main Business
5.3.3 Lonza Group Mycoplasma Testing Products, Services and Solutions
5.3.4 Lonza Group Mycoplasma Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Roche Diagnostics Recent Developments
5.4 Roche Diagnostics
5.4.1 Roche Diagnostics Profile
5.4.2 Roche Diagnostics Main Business
5.4.3 Roche Diagnostics Mycoplasma Testing Products, Services and Solutions
5.4.4 Roche Diagnostics Mycoplasma Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Roche Diagnostics Recent Developments
5.5 SGS
5.5.1 SGS Profile
5.5.2 SGS Main Business
5.5.3 SGS Mycoplasma Testing Products, Services and Solutions
5.5.4 SGS Mycoplasma Testing Revenue (US$ Million) & (2018-2023)
5.5.5 SGS Recent Developments
5.6 Thermo Fisher Scientific
5.6.1 Thermo Fisher Scientific Profile
5.6.2 Thermo Fisher Scientific Main Business
5.6.3 Thermo Fisher Scientific Mycoplasma Testing Products, Services and Solutions
5.6.4 Thermo Fisher Scientific Mycoplasma Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Thermo Fisher Scientific Recent Developments
5.7 American Type Culture Collection
5.7.1 American Type Culture Collection Profile
5.7.2 American Type Culture Collection Main Business
5.7.3 American Type Culture Collection Mycoplasma Testing Products, Services and Solutions
5.7.4 American Type Culture Collection Mycoplasma Testing Revenue (US$ Million) & (2018-2023)
5.7.5 American Type Culture Collection Recent Developments
5.8 Biounique Testing Laboratories
5.8.1 Biounique Testing Laboratories Profile
5.8.2 Biounique Testing Laboratories Main Business
5.8.3 Biounique Testing Laboratories Mycoplasma Testing Products, Services and Solutions
5.8.4 Biounique Testing Laboratories Mycoplasma Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Biounique Testing Laboratories Recent Developments
5.9 Invivogen
5.9.1 Invivogen Profile
5.9.2 Invivogen Main Business
5.9.3 Invivogen Mycoplasma Testing Products, Services and Solutions
5.9.4 Invivogen Mycoplasma Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Invivogen Recent Developments
5.10 Promocell
5.10.1 Promocell Profile
5.10.2 Promocell Main Business
5.10.3 Promocell Mycoplasma Testing Products, Services and Solutions
5.10.4 Promocell Mycoplasma Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Promocell Recent Developments
5.11 Biological Industries Israel Beit Haemek
5.11.1 Biological Industries Israel Beit Haemek Profile
5.11.2 Biological Industries Israel Beit Haemek Main Business
5.11.3 Biological Industries Israel Beit Haemek Mycoplasma Testing Products, Services and Solutions
5.11.4 Biological Industries Israel Beit Haemek Mycoplasma Testing Revenue (US$ Million) & (2018-2023)
5.11.5 Biological Industries Israel Beit Haemek Recent Developments
5.12 Wuxi Apptec
5.12.1 Wuxi Apptec Profile
5.12.2 Wuxi Apptec Main Business
5.12.3 Wuxi Apptec Mycoplasma Testing Products, Services and Solutions
5.12.4 Wuxi Apptec Mycoplasma Testing Revenue (US$ Million) & (2018-2023)
5.12.5 Wuxi Apptec Recent Developments
5.13 Norgen Biotek
5.13.1 Norgen Biotek Profile
5.13.2 Norgen Biotek Main Business
5.13.3 Norgen Biotek Mycoplasma Testing Products, Services and Solutions
5.13.4 Norgen Biotek Mycoplasma Testing Revenue (US$ Million) & (2018-2023)
5.13.5 Norgen Biotek Recent Developments
6 North America
6.1 North America Mycoplasma Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Mycoplasma Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Mycoplasma Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Mycoplasma Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Mycoplasma Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Mycoplasma Testing Market Dynamics
11.1 Mycoplasma Testing Industry Trends
11.2 Mycoplasma Testing Market Drivers
11.3 Mycoplasma Testing Market Challenges
11.4 Mycoplasma Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Food & Beverages Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
